Dayyani, F., Zurita, A. J., Nogueras-González, G. M., Slack, R., Millikan, R. E., Araujo, J. C., . . . Corn, P. G. (2016). The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study. BMC Cancer.
Chicago-стиль цитированияDayyani, Farshid, Amado J. Zurita, Graciela M. Nogueras-González, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis, and Paul G. Corn. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.
MLA-цитированиеDayyani, Farshid, et al. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.